Status:

COMPLETED

Post Market Clinical Follow-Up Study on the Performance and Safety of Lyoplant®

Lead Sponsor:

Aesculap AG

Conditions:

Tumor, Cerebral Ventricle

Tumor, Cerebellar

Eligibility:

All Genders

18+ years

Brief Summary

Retrospective, single center, single arm PMCF study on the performance and safety of Lyoplant® used for the replacement and extension of connective tissue structures in neurosurgery.

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • Use of investigational device according to Instructions for Use (IfU)

Exclusion

  • none

Key Trial Info

Start Date :

April 2 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 10 2025

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT05441618

Start Date

April 2 2024

End Date

January 10 2025

Last Update

January 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universitätsklinikum Augsburg AöR

Augsburg, Bavaria, Germany, 86156